IntraBiotics starts Protegrin Phase IIa

IBPI began a 40-patient U.S. Phase II study of its Protegrin IB-367 rinse, a synthetic antimicrobial peptide analog, to prevent ventilator-associated pneumonia. The product is in Phase III testing to ...